Home › NDC Lookup › RxCUI directory › RxCUI 2594982

2 ML rilpivirine 300 MG/ML Injection — RxCUI 2594982

Name: 2 ML rilpivirine 300 MG/ML Injection (RxCUI 2594982)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2594982 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2594982

Official name2 ML rilpivirine 300 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asrilpivirine 600 MG per 2 ML Injection; rilpivirine 600 MG in 2 ML Extended Release Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)57,556 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rilpivirine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Rilpivirine is one piece of your HIV treatment — it blocks a specific enzyme the virus uses to copy itself. But HIV is smart and can develop resistance if only one medicine is used...
What exactly is rilpivirine and why do I have to take it with other HIV medicines?
It really does matter. When rilpivirine is taken without food, your body absorbs about 40% less of the medicine — and if levels in your blood fall too low, the virus can start repl...
Why is it so important to take this with food? Can't I just take it whenever?

📖 Read our full Rilpivirine guide →

🕸️ Concept Web — How 2 ML rilpivirine 300 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 2 ML rilpivirine 300 MG/ML Injection RxCUI 2594982 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Rilpivirine 1102270 IN
Dose forms 4

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Rilpivirine Injection 2594979 SCDF
- Rilpivirine Injectable Product 2475412 SCDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Rilpivirine 300 MG/ML 2475411 SCDC
Packs 2

Fixed collections of drugs packaged and sold together, like dose packs.
- {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG] 2475418 BPCK
- {1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack 2475417 GPCK

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack GPCK · 2475417
Rilpivirine 300 MG/ML SCDC · 2475411
Rilpivirine Injection SCDF · 2594979
Rilpivirine Injectable Product SCDG · 2475412

Brand-Name Concepts

{1 (2 ML cabotegravir 200 MG/ML Injection) / 1 (2 ML rilpivirine 300 MG/ML Injection) } Pack [CABENUVA 400 MG / 600 MG] BPCK · 2475418

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 2594982 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
49702-0240-15	1 KIT in 1 CARTON (49702-240-15) * 3 mL in 1 VIAL (49702-2...	Cabenuva	ViiV Healthcare Company	2021-01-21
49702-0253-15	1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-2...	Cabenuva	ViiV Healthcare Company	2021-01-21
49702-0266-63	1 KIT in 1 CARTON (49702-266-63) * 3 mL in 1 VIAL (49702-2...	Cabenuva	ViiV Healthcare Company	2025-01-21

Observed labelers: ViiV Healthcare Company (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0741	Inj, cabote rilpivir 2mg 3mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.